Age and Ageing · 2016 · 174 citations · 12 references
PharmacyClinical PharmacyGeriatric MedicineGeriatric AssessmentGeriatric CareGeriatricsChronic Disease PharmacotherapyComprehensive Geriatric AssessmentMedication Adherence In Older AdultsMedication ReviewMedication UsePotentially Inappropriate MedicationsComprehensive Geriatric Medication ReviewControl Group DesignElderly Medication ManagementGeriatric Medication AssessmentGeriatric Medication ErrorsMatched Control GroupMedication Dosing ErrorsMedication Management Errors
TRIAL DESIGN: to further validate the FORTA (Fit fOR The Aged) concept, a bicentric randomised, controlled trial was run in two geriatric clinics. METHODS: patients (≥65 years, ≥3 drugs or ≥60 years, ≥6 drugs) with three relevant diseases and hospitalisation for ≥5 days were randomised. In the intervention, but not the control group, a FORTA team instructed ward physicians on FORTA. FORTA is the first positive/negative listing approach labelling medications used to treat chronic illnesses in older patients from A (indispensable), B (beneficial), C (questionable) to D (avoid). The primary end point was the FORTA score: sum of medication errors classified as over-, under- and mistreatment. Consecutive patients were randomised to the intervention and control ward; outcome assessment was blinded. RESULTS: four hundred and nine patients (age 81.5 years, 64% female, hospitalisation 17.4 days) were included. The primary end point was significantly (P < 0.0001) more reduced in the intervention versus control groups (2.7 ± 2.25 versus 1 ± 1.8, mean ± SD, intergroup comparison of admission/discharge differences). Over- and under-treatment scores and use of A (increase) and D (decrease) drugs were significantly improved (P < 0.01). The total number of adverse drug reactions (ADRs) was significantly reduced by FORTA (P < 0.05, number needed to treat is 5). Activities of daily living and renal failure improved significantly (P < 0.05). Blood pressure remained constant in the intervention, but decreased significantly in the control group. CONCLUSION: applying FORTA to hospitalised geriatric patients leads to improvement of medication quality and may improve secondary clinical end points (e.g. ADRs). The concept is amenable to successful communication and implementation. Registration (DRKS-ID): DRKS00000531. FUNDING: DFG-German Research Foundation (WE 1184/15-1).
12
Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States
David W. Kaufman, Judith P. Kelly, Lynn Rosenberg et al. · JAMA · 2002 · 1.8K citations
Paul Gallagher, Cristín Ryan, Shauna E. Byrne et al. · International Journal of Clinical Pharmacology and Therapeutics · 2008 · 1.5K citations